Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Agger Mette Kirstine Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 17,300 options to buy @ $11.71, valued at $202.6k
06/11/2020 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 6,124 options to buy @ $7.96, valued at $48.7k
03/16/2020 4 Agger Mette Kirstine (10% Owner) has filed a Form 4 on IMARA Inc.
Txns: Converted 1,245,222 shares @ $0
Bought 187,500 shares @ $16, valued at $3M
Converted 478,749 options to buy @ $0
Converted 5,470,492 preferred shares @ $0
Converted 1,894,444 preferred shares @ $0
Granted 15,457 options to buy @ $16, valued at $247.3k
03/11/2020 3 Agger Mette Kirstine (10% Owner) has filed a Form 3 on IMARA Inc.
06/20/2019 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 6,124 options to buy @ $3.37, valued at $20.6k
05/13/2019 4 Agger Mette Kirstine (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Converted 776,544 shares @ $0
Bought 375,000 shares @ $10, valued at $3.8M
Converted 6,849,315 preferred shares @ $0
05/08/2019 4 Agger Mette Kirstine (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 23,684 options to buy @ $10, valued at $236.8k
05/07/2019 3 Agger Mette Kirstine (Director) has filed a Form 3 on Trevi Therapeutics, Inc.
06/21/2018 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Granted 6,124 options to buy @ $5.53, valued at $33.9k
02/13/2018 4/A Agger Mette Kirstine (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Bought 654,762 shares @ $14, valued at $9.2M
11/21/2017 4 Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Converted 1,544,858 shares @ $0
Converted 984,366 shares @ $0
Converted 11,092,383 preferred shares @ $0
Converted 7,067,945 preferred shares @ $0
11/16/2017 3 Agger Mette Kirstine (Director) has filed a Form 3 on scPharmaceuticals Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy